What makes effective policy for the life sciences and health?

1 May 2017


What makes effective policy for the life sciences and health?

The pace of scientific innovation across the life sciences has never been faster, and the implications of many of these innovations pose significant issues for policy-makers, especially for applications relating to human health.

At this latest Life Sciences and Society conference, on 25 May, the aim is to untangle the complex interplay of biomedical science and ethical, legal and social issues that arise when developing policy in this area.

International guest specialists will present for discussion their perspectives on effective policy making, with experts from University of Cambridge ready to respond.

On the agenda:

Law and policymaking for gene editing

  • Prof Bartha Knoppers (Director, Centre of Genomics and Policy, McGill University)
  • Dr Rumiana Yotova (Fellow in Law and Director of Studies at Lucy Cavendish College, University of Cambridge)

Evidence, ethics and epistemology in policy-making for gene editing

  • Dr Eric Meslin (President and CEO, Council of Canadian Academies)
  • Prof Tim Lewens (Professor of Philosophy of Science, University of Cambridge)

This half-day event begins with lunch and there will be plenty of time for discussion, debate and networking. Tickets can be booked here

The conference is the latest in the Life Sciences and Society series, an initiative of the PHG Foundation, a Cambridge think-tank working to ensure biomedical innovation delivers better health for all. The series is run in partnership with Cambridge University Health Partners and Hughes Hall.

Genomics and policy news

Sign up